Cell therapy for ischaemic heart disease: Focus on the role of resident cardiac stem cells

S. A J Chamuleau, K. R. Vrijsen, D. G. Rokosh, X. L. Tang, J. J. Piek, R. Bolli

Research output: Contribution to journalArticle

Abstract

Myocardial infarction results in loss of cardiomyocytes, scar formation, ventricular remodelling, and eventually heart failure. In recent years, cell therapy has emerged as a potential new strategy for patients with ischaemic heart disease. This includes embryonic and bone marrow derived stem cells. Recent clinical studies showed ostensibly conflicting results of intracoronary infusion of autologous bone marrow derived stem cells in patients with acute or chronic myocardial infarction. Anyway, these results have stimulated additional clinical and pre-clinical studies to further enhance the beneficial effects of stem cell therapy. Recently, the existence of cardiac stem cells that reside in the heart itself was demonstrated. Their discovery has sparked intense hope for myocardial regeneration with cells that are obtained from the heart itself and are thereby inherently programmed to reconstitute cardiac tissue. These cells can be detected by several surface markers (e.g. c-kit, Sca-1, MDR1, Isl-1). Both in vitro and in vivo differentiation into cardiomyocytes, endothelial cells and vascular smooth muscle cells has been demonstrated, and animal studies showed promising results on improvement of left ventricular function. This review will discuss current views regarding the feasibility of cardiac repair, and focus on the potential role of the resident cardiac stem and progenitor cells.

Original languageEnglish (US)
Pages (from-to)199-207
Number of pages9
JournalNetherlands Heart Journal
Volume17
Issue number5
StatePublished - May 2009
Externally publishedYes

Fingerprint

Cell- and Tissue-Based Therapy
Myocardial Ischemia
Stem Cells
Cardiac Myocytes
Bone Marrow
Myocardial Infarction
Ventricular Remodeling
Vascular Smooth Muscle
Left Ventricular Function
Smooth Muscle Myocytes
Cicatrix
Regeneration
Endothelial Cells
Heart Failure

Keywords

  • Cardiac stem cell
  • Ischaemic heart disease
  • Regeneration
  • Stem cell therapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Chamuleau, S. A. J., Vrijsen, K. R., Rokosh, D. G., Tang, X. L., Piek, J. J., & Bolli, R. (2009). Cell therapy for ischaemic heart disease: Focus on the role of resident cardiac stem cells. Netherlands Heart Journal, 17(5), 199-207.

Cell therapy for ischaemic heart disease : Focus on the role of resident cardiac stem cells. / Chamuleau, S. A J; Vrijsen, K. R.; Rokosh, D. G.; Tang, X. L.; Piek, J. J.; Bolli, R.

In: Netherlands Heart Journal, Vol. 17, No. 5, 05.2009, p. 199-207.

Research output: Contribution to journalArticle

Chamuleau, SAJ, Vrijsen, KR, Rokosh, DG, Tang, XL, Piek, JJ & Bolli, R 2009, 'Cell therapy for ischaemic heart disease: Focus on the role of resident cardiac stem cells', Netherlands Heart Journal, vol. 17, no. 5, pp. 199-207.
Chamuleau SAJ, Vrijsen KR, Rokosh DG, Tang XL, Piek JJ, Bolli R. Cell therapy for ischaemic heart disease: Focus on the role of resident cardiac stem cells. Netherlands Heart Journal. 2009 May;17(5):199-207.
Chamuleau, S. A J ; Vrijsen, K. R. ; Rokosh, D. G. ; Tang, X. L. ; Piek, J. J. ; Bolli, R. / Cell therapy for ischaemic heart disease : Focus on the role of resident cardiac stem cells. In: Netherlands Heart Journal. 2009 ; Vol. 17, No. 5. pp. 199-207.
@article{961b8ce63b334b16baf8c71a2f3f0798,
title = "Cell therapy for ischaemic heart disease: Focus on the role of resident cardiac stem cells",
abstract = "Myocardial infarction results in loss of cardiomyocytes, scar formation, ventricular remodelling, and eventually heart failure. In recent years, cell therapy has emerged as a potential new strategy for patients with ischaemic heart disease. This includes embryonic and bone marrow derived stem cells. Recent clinical studies showed ostensibly conflicting results of intracoronary infusion of autologous bone marrow derived stem cells in patients with acute or chronic myocardial infarction. Anyway, these results have stimulated additional clinical and pre-clinical studies to further enhance the beneficial effects of stem cell therapy. Recently, the existence of cardiac stem cells that reside in the heart itself was demonstrated. Their discovery has sparked intense hope for myocardial regeneration with cells that are obtained from the heart itself and are thereby inherently programmed to reconstitute cardiac tissue. These cells can be detected by several surface markers (e.g. c-kit, Sca-1, MDR1, Isl-1). Both in vitro and in vivo differentiation into cardiomyocytes, endothelial cells and vascular smooth muscle cells has been demonstrated, and animal studies showed promising results on improvement of left ventricular function. This review will discuss current views regarding the feasibility of cardiac repair, and focus on the potential role of the resident cardiac stem and progenitor cells.",
keywords = "Cardiac stem cell, Ischaemic heart disease, Regeneration, Stem cell therapy",
author = "Chamuleau, {S. A J} and Vrijsen, {K. R.} and Rokosh, {D. G.} and Tang, {X. L.} and Piek, {J. J.} and R. Bolli",
year = "2009",
month = "5",
language = "English (US)",
volume = "17",
pages = "199--207",
journal = "Netherlands Heart Journal",
issn = "1568-5888",
publisher = "Bohn Stafleu van Loghum",
number = "5",

}

TY - JOUR

T1 - Cell therapy for ischaemic heart disease

T2 - Focus on the role of resident cardiac stem cells

AU - Chamuleau, S. A J

AU - Vrijsen, K. R.

AU - Rokosh, D. G.

AU - Tang, X. L.

AU - Piek, J. J.

AU - Bolli, R.

PY - 2009/5

Y1 - 2009/5

N2 - Myocardial infarction results in loss of cardiomyocytes, scar formation, ventricular remodelling, and eventually heart failure. In recent years, cell therapy has emerged as a potential new strategy for patients with ischaemic heart disease. This includes embryonic and bone marrow derived stem cells. Recent clinical studies showed ostensibly conflicting results of intracoronary infusion of autologous bone marrow derived stem cells in patients with acute or chronic myocardial infarction. Anyway, these results have stimulated additional clinical and pre-clinical studies to further enhance the beneficial effects of stem cell therapy. Recently, the existence of cardiac stem cells that reside in the heart itself was demonstrated. Their discovery has sparked intense hope for myocardial regeneration with cells that are obtained from the heart itself and are thereby inherently programmed to reconstitute cardiac tissue. These cells can be detected by several surface markers (e.g. c-kit, Sca-1, MDR1, Isl-1). Both in vitro and in vivo differentiation into cardiomyocytes, endothelial cells and vascular smooth muscle cells has been demonstrated, and animal studies showed promising results on improvement of left ventricular function. This review will discuss current views regarding the feasibility of cardiac repair, and focus on the potential role of the resident cardiac stem and progenitor cells.

AB - Myocardial infarction results in loss of cardiomyocytes, scar formation, ventricular remodelling, and eventually heart failure. In recent years, cell therapy has emerged as a potential new strategy for patients with ischaemic heart disease. This includes embryonic and bone marrow derived stem cells. Recent clinical studies showed ostensibly conflicting results of intracoronary infusion of autologous bone marrow derived stem cells in patients with acute or chronic myocardial infarction. Anyway, these results have stimulated additional clinical and pre-clinical studies to further enhance the beneficial effects of stem cell therapy. Recently, the existence of cardiac stem cells that reside in the heart itself was demonstrated. Their discovery has sparked intense hope for myocardial regeneration with cells that are obtained from the heart itself and are thereby inherently programmed to reconstitute cardiac tissue. These cells can be detected by several surface markers (e.g. c-kit, Sca-1, MDR1, Isl-1). Both in vitro and in vivo differentiation into cardiomyocytes, endothelial cells and vascular smooth muscle cells has been demonstrated, and animal studies showed promising results on improvement of left ventricular function. This review will discuss current views regarding the feasibility of cardiac repair, and focus on the potential role of the resident cardiac stem and progenitor cells.

KW - Cardiac stem cell

KW - Ischaemic heart disease

KW - Regeneration

KW - Stem cell therapy

UR - http://www.scopus.com/inward/record.url?scp=70349293932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349293932&partnerID=8YFLogxK

M3 - Article

C2 - 19484156

AN - SCOPUS:70349293932

VL - 17

SP - 199

EP - 207

JO - Netherlands Heart Journal

JF - Netherlands Heart Journal

SN - 1568-5888

IS - 5

ER -